Jacobs Levy Equity Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-72,163
Closed -$744K 1108
2023
Q3
$744K Sell
72,163
-40,460
-36% -$384K ﹤0.01% 726
2023
Q2
$929K Sell
112,623
-119,029
-51% -$712K 0.01% 707
2023
Q1
$1.29M Sell
231,652
-246,505
-52% -$1.41M 0.01% 652
2022
Q4
$2.37M Sell
478,157
-148,653
-24% -$612K 0.02% 522
2022
Q3
$3.01M Buy
626,810
+452,154
+259% +$1.94M 0.02% 481
2022
Q2
$449K Sell
174,656
-4,422
-2% -$16.6K ﹤0.01% 884
2022
Q1
$1.03M Buy
+179,078
New +$1.61M 0.01% 749

Other funds holding TRHC

Jacobs Levy Equity Management's TRHC Position: Q4 2023 in Review

Jacobs Levy Equity Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 72,163 shares — an estimated $744K sold.

Jacobs Levy Equity Management first reported a position in TRHC in Q1 2022 and held it in 7 quarters. The position peaked at $3.01M in Q3 2022. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Jacobs Levy Equity Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 72,163 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $744K.
  • Jacobs Levy Equity Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Jacobs Levy Equity Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $3.01M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.